Kirkland Advises on ImmuneOnco Biopharmaceuticals Hong Kong IPO

Advising firms

The announcement does not name individual lawyers.

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value

USD 40.7m ($40.7 million)

What the figure measures

Issue size

Client

Not stated

Counterparties

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (Issuer)
Morgan Stanley Asia Limited (Underwriters)
China International Capital Corporation Hong Kong Securities Limited (Underwriters)